Octagam® 10% is an immunoglobulin for intravenous use, which is used for replacement therapy in primary and secondary immunodeficiency and for immunomodulation associated with certain autoimmune diseases. Octagam® 10% is a ready-to-use solution available in Australia as a 10% concentration.
For more information, review the Australian Approved Product Information available here.
Our other Australian registered products:
Octapharma Australia maintains a portfolio of other TGA registered products.
For commercial enquiries or further information about any of the following products (including the Australian Approved Product Information), please contact our Australian office using the CONTACT US form.
Registered Product: | |
---|---|
Octagam 5%® | Human normal immunoglobulin, for intravenous injection. |
Gammanorm® | Human normal immunoglobulin 165mg/mL, for intramuscular or subcutaneous injection. |
Pronativ® | Human prothrombin complex, powder for intravenous injection. |
Octanate® | Human coagulation factor VIII, powder for intravenous injection. |
Wilate® | Human coagulation factor VIII (FVIII) and von Willebrand factor (VWF), powder for intravenous injection. |
Octaplas LG® | Solvent/detergent (S/D) treated human plasma, for intravenous injection. |
Nuwiq® | Simoctocog alfa (human recombinant coagulation factor VIII) powder for intravenous injection. |
Panzyga® | Human normal immunoglobulin 10% (100mg/mL), for intravenous injection. |
Cutaquig® | Human normal immunoglobulin 16.5% (165mg/mL), for subcutaneous injection. |
If you are from another country, visit the global Octapharma website and select your relevant local country to review your country-specific information.
To contact your local Octapharma Australia team click here.